APOE and COVID-19: Recently, Kuo et al. found that APOE ε4/ε4 homozygotes exhibit a more than two-fold higher susceptibility to COVID-19 [110, 111] and a four-fold higher risk of mortality than APOE ε3/ε3 homozygotes, according to data from the UK Biobank cohort [110, 111].